Targeted transperineal biopsy of the prostate has limited additional benefit over background cores for larger MRI-identified tumors - Summary - MDSpire
Advertisement
Targeted transperineal biopsy of the prostate has limited additional benefit over background cores for larger MRI-identified tumors
To compare the characteristics of targets in patients undergoing standardized MRI-guided prostate biopsy and identify when targeted cores are most beneficial in terms of cancer yield and grade stratification, specifically focusing on detection rates and tumor aggressiveness.
Key Findings:
MRI-targeted biopsies have higher detection rates for clinically significant cancer compared to systematic biopsies, which may influence treatment decisions.
The need for additional background cores is debated due to potential increased morbidity and costs, highlighting the need for careful consideration in clinical practice.
Interpretation:
While MRI-targeted biopsies improve cancer detection, the additional benefit of targeted cores over background cores for larger tumors may be limited, suggesting a need for tailored biopsy strategies.
Limitations:
The study is retrospective and may not account for all variables, which could influence the generalizability of the findings.
The experience of the radiologist can affect MRI accuracy, potentially impacting the study's outcomes.
General anesthesia requirements may limit the approach's widespread use, affecting patient accessibility.
Conclusion:
Determining the optimal number of biopsy cores is crucial to balance cancer detection with the risk of false negatives and patient morbidity, emphasizing the need for further research to refine biopsy protocols.
by Tristan Barrett, Andrew J. Patterson, Brendan C. Koo, Karan Wadhwa, Anne Y. Warren, Andrew Doble, Vincent J. Gnanapragasam, Christof Kastner, Ferdia A. Gallagher
